Martin Rakuša

ADAMANT: a placebo-controlled randomized phase 2 study of AADvac1, an active immunotherapy against pathological tau in Alzheimer’s disease

Petr Novák, Branislav Kováčech, Stanislav Katina et al. · Nature Aging · 2021 · 168 citations

Neurodegenerative Diseases, Alzheimer's Disease, Active Immunotherapy +9

The international European Academy of Neurology survey on neurological symptoms in patients with COVID‐19 infection

Elena Moro, Alberto Priori, Ettore Beghi et al. · European Journal of Neurology · 2020 · 112 citations · Full text

European* clinical practice recommendations on opioids for chronic noncancer pain – Part 1: Role of opioids in the management of chronic noncancer pain

Winfried Häuser, Bart Morlion, Kevin E. Vowles et al. · European Journal of Pain · 2021 · 105 citations · Full text

Morphometric analysis of skeletal muscle capillary ultrastructure in inflammatory myopathies

F. Jerusalem, Martin Rakuša, Andrew G. Engel et al. · Journal of the Neurological Sciences · 1974 · 91 citations

Skeletal Muscle, Biomechanics, Histopathology +7

Association between CSF biomarkers of Alzheimer's disease and neuropsychiatric symptoms: Mayo Clinic Study of Aging

Janina Krell‐Roesch, Martin Rakuša, Jeremy A. Syrjanen et al. · Alzheimer s & Dementia · 2022 · 51 citations · Full text